Who Is Angela Fisher? Clinical Psychologist and Founder of Bionic Bloom
Profile of clinical psychologist Dr. Angela Fisher, founder and clinical director of Bionic Bloom.
Dr. Angela Fisher is a clinical psychologist who holds a PhD and serves as the founder and clinical director of Bionic Bloom.
At Mind Medicine Law, we track the people building legal, evidence-based access to psychedelic medicine: the companies running the trials, the researchers and advocates behind them, and the officials who write and run the laws.
She founded the first legal psilocybin therapy center in the United States, established the Neurodivergent Empowerment Institute, and created Empowerment-Based Integrated Treatment (EBiT).
Where Angela Fisher Is Now
- Current Role: Clinical psychologist, clinical director, and Chancellor of Sacred Bloom College of Healing Arts
- Organization: Founder and clinical director of Bionic Bloom; founder of the Neurodivergent Empowerment Institute; leader of a national network of integrative health clinics
- Known For: Founding the first legal psilocybin therapy center in the United States and creating Empowerment-Based Integrated Treatment (EBiT)
- Recent News: Selected to deliver in-person oral public comments at the U.S. FDA's public hearing on the therapeutic use of psychedelic drugs
Dr. Angela Fisher holds clinical, academic, and organizational leadership positions across healthcare and education, according to Newswire.
Career and Organizations Founded
Angela Fisher is a clinical psychologist holding a PhD who created Empowerment-Based Integrated Treatment (EBiT), as reported by Newswire. She is the founder of Bionic Bloom and also established the Neurodivergent Empowerment Institute.
Fisher founded the first legal psilocybin therapy center in the United States, serves as the clinical director of Bionic Bloom, serves as Chancellor of Sacred Bloom College of Healing Arts, and leads a national network of integrative health clinics, according to Newswire.
Public Appearances and FDA Hearing
Fisher was scheduled to speak at Cannadelic Miami 2025 in May 2025, per Newswire.
She was selected to deliver in-person oral public comments at the U.S. Food and Drug Administration's 'Considerations for Potential Future Therapeutic Use of Psychedelic Drugs' Public Hearing scheduled for September 14, 2026, at the FDA's White Oak Campus in Silver Spring, Maryland, according to Newswire.
Perspectives on Psychedelic Care and Facilitator Standards
Fisher stated that while clinical trials are intentionally guarded to control variables and protect participants, real-world patients often present with conditions such as autism, ADHD, OCD, trauma, and chronic illness, as reported by Newswire. She asserted that a clinical trial should inform safe care rather than become the permanent standard of care, and cautioned that reproducing clinical trials in ordinary treatment rooms risks making psychedelic medicine unaffordable.
Fisher advocates for risk-stratified psychedelic care where the level of clinical support is tailored to patient complexity. She also advocated for studying comorbidity in psychedelic care as a clinical variable rather than merely treating it as a confounder, and pointed out that some psychedelic substances have traditional histories of human use extending thousands of years.
On facilitator training, Fisher proposed a competency model spanning preparing, facilitating, anticipating, and integrating across an entire episode of care. She stated that the psychedelic experience is not the outcome and emphasized the importance of post-session changes in a person's life, arguing against certifying facilitators solely on managing altered consciousness and calling for training them to care for patients post-treatment.
Regarding healthcare coverage for veterans, Fisher stated that accepting TRICARE allows care honoring the complexity of trauma to reach veterans, according to FinancialContent.
Frequently asked questions
Who is Angela Fisher?
Dr. Angela Fisher is a clinical psychologist with a PhD who founded Bionic Bloom and the Neurodivergent Empowerment Institute, and created Empowerment-Based Integrated Treatment (EBiT).
What organizations does Dr. Angela Fisher lead?
Fisher is the founder and clinical director of Bionic Bloom, founder of the Neurodivergent Empowerment Institute, Chancellor of Sacred Bloom College of Healing Arts, and leader of a national network of integrative health clinics.
What milestone center did Angela Fisher establish in the U.S.?
Angela Fisher founded the first legal psilocybin therapy center in the United States.
What role was Angela Fisher selected for at the FDA public hearing?
She was selected to deliver in-person oral public comments at the FDA's 'Considerations for Potential Future Therapeutic Use of Psychedelic Drugs' Public Hearing on September 14, 2026, at the FDA's White Oak Campus in Silver Spring, Maryland.
What are Dr. Fisher's views on psychedelic clinical trials?
Fisher asserted that clinical trials should inform safe care rather than become the permanent standard of care, cautioning that replicating clinical trials in ordinary treatment rooms risks making psychedelic medicine unaffordable. She also stated that real-world patients often have conditions such as autism, ADHD, OCD, trauma, and chronic illness.
What competency model did Dr. Fisher propose for psychedelic facilitators?
Fisher proposed a competency model for psychedelic facilitators that covers preparing, facilitating, anticipating, and integrating across an entire episode of care, arguing against certifying facilitators solely on managing altered consciousness.
Sources
General information compiled from the public reporting cited above, not medical or legal advice. Mention of a treatment, trial or bill is not a claim that it is safe, effective or legal where you live. Not endorsed by or affiliated with Angela Fisher or Bionic Bloom. See more people in psychedelic medicine.